Larsen, A. T., Gydesen, S., Sonne, N., Karsdal, M. A., & Henriksen, K. (2021). The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile. BMC Endocr Disord.

Larsen, Anna Thorsø, Sofie Gydesen, Nina Sonne, Morten Asser Karsdal, and Kim Henriksen. "The Dual Amylin and Calcitonin Receptor Agonist KBP-089 and the GLP-1 Receptor Agonist Liraglutide Act Complimentarily On Body Weight Reduction and Metabolic Profile." BMC Endocr Disord 2021.

Larsen, Anna Thorsø, et al. "The Dual Amylin and Calcitonin Receptor Agonist KBP-089 and the GLP-1 Receptor Agonist Liraglutide Act Complimentarily On Body Weight Reduction and Metabolic Profile." BMC Endocr Disord 2021.